Hardman Johnston Global Advisors LLC Astrazeneca PLC Transaction History
Hardman Johnston Global Advisors LLC
- $2.25 Billion
- Q4 2024
A detailed history of Hardman Johnston Global Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 523,164 shares of AZN stock, worth $37.7 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
523,164
Previous 558,488
6.32%
Holding current value
$37.7 Million
Previous $43.5 Million
21.23%
% of portfolio
1.52%
Previous 1.77%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,350Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.53 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.02 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.68 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.65 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...